CPT code 84080 represents a laboratory assay that separates and quantifies alkaline phosphatase (ALP) isoenzymes. This test helps clinicians determine the tissue origin of abnormal ALP activity, which can be clinically important for differentiating liver, bone, and other disorders. Nationally, accurate reporting of this code supports clinical decision-making and appropriate laboratory reimbursement pathways for specialized enzymatic analysis.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, common billing modifiers applicable to laboratory services, and typical sites of service for this assay. The publication also provides clinical context for when isoenzyme analysis is ordered and summarizes coding considerations relevant to laboratory billing teams.

The content highlights benchmarks and policy-relevant points that affect utilization and coding of specialized laboratory procedures. Data not available in the input is noted where applicable, and the focus remains on national implications for clinical laboratories, hospital labs, and billing departments responsible for correctly reporting CPT code 84080.